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Summary Respiratory syncytial virus (RSV) subtypes A and B are present either
simultaneously or alternate during yearly epidemics. It is still not clear whether
clinical severity of acute bronchiolitis differs between the two subtypes.
Reverse transcription polymerase chain reaction was used to subtype RSV in
previously healthy infants hospitalized with RSV bronchiolitis during a winter
epidemic. A severity index based on heart rate, respiratory rate, wheezing, difficulty
in feeding and oxygen saturation was calculated upon admission.
Infants infected with RSV subtype-A were found to have a significantly higher
(more severe) clinical score than those infected with RSV-B. There was no
statistically significant difference in duration of hospitalization or need of intensive
care. Boys and infants younger than 3 months of age were also more severely
affected than girls or older infants, respectively.
These results support the notion that RSV-A-induced bronchiolitis is more severe
than RSV-B-induced one, in agreement with the majority of previously published
studies.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Bronchiolitis is an acute respiratory illness of
children in the first 2 years of life mostly associated
with respiratory syncytial virus (RSV).1,2 Two RSV
subtypes, A and B have been identified3 with
antigenic differences sufficiently extensive to
affect susceptibility to infection or disease.4 How-
ever, direct comparisons between subtypes in
terms of disease severity have produced contro-
versial results. RSV-A5–8 or RSV-B9 were found to
result in more severe infection, however, an equal
number of investigations have failed to confirm any
difference.10–12 These discrepancies could be at-
tributed to differences in study design, which in
most cases has been retrospective, disease defini-
tion, inclusion criteria, outcome measures or
subtyping methodology. Furthermore, it is possible
that strain virulence may be variable between
epidemics. As more therapeutic and prophylactic
modalities against RSV are becoming available,
possible differences in disease severity between
subtypes may in the future have an effect on
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may be differences in the severity of bronchiolitis
caused by different RSV subtypes and aimed to
investigate prospectively any such differences in
infants hospitalized with the disease.
Material and methods
Study subjects
Eighty-one infants (45 boys) with mean age
3.570.3 months (range 0.5–12) hospitalized with
a clinical diagnosis of bronchiolitis and positive RSV
immunofluorescence test were included in the
study. Bronchiolitis was defined as an acute infec-
tion of the lower airway characterized by increased
respiratory effort (450 respirations/min and/or
use of accessory respiratory muscles), and expira-
tory wheezing and/or crackles. A detailed ques-
tionnaire and a nasopharyngeal aspirate (NPA) were
obtained upon admission. Disease severity was
assessed based on heart rate, respiratory rate,
wheezing, evidence of cyanosis or difficulty of
feeding, and oxygen saturation as previously
described.13 Infants with underlying chronic dis-
eases or recurrent (42) wheezing episodes were
excluded. Informed consent was obtained from
parents. Infants were managed and discharged
according to routine clinical practices.
RSV typing
RSV-A and -B subtypes were characterized by a
multiplex nested reverse transcription-PCR (RT-
PCR), according to a published protocol.14 Primers
were obtained from MWC-Biotech, Munich, Ger-
many. Amplicons were visualized by ethidium
bromide staining after electrophoresis on a 1.5%
agarose gel (Gibco). Amplicon size (RSV-A¼ 334,
RSV-B¼ 183) was used to differentiate between the
subtypes. Reference viral strains were included as
positive controls; several negative controls were
also included in each run.
Statistical analysis
Continuous variables were analyzed with one-way
analysis of variance (ANOVA) and Student’s t-test;
chi-square was performed for ordinal or categorical
data. Continuous data are expressed as mean 7
standard error of mean. Po0.05 was considered
significant.
Results
Forty-eight samples were positive for either RSV-A
or RSV-B by PCR (59%). Sub-grouped cases had more
frequently a positive family history of atopy (37.0%
vs. 15.6%, P¼ 0.039) and a marginally higher
severity index (8.7970.2 vs. 8.1570.3, P¼ 0.075,
t-test), with no other differences in demographic or
disease characteristics. Of the sub-grouped sam-
ples 23 (48%) were RSV-A and 25 (52%) RSV-B.
Table 1 summarizes the data in the three groups
(RSV-A, RSV-B, non-subtyped). Age, sex, birth
weight, day of disease at admission, duration of
hospitalization, pre or postnatal exposure to
tobacco smoke, family history of atopy, presence
of fever, leukocyte count and differential, ESR, CRP
and IgE had no significant differences in respect to
subtype (data not shown). Moreover, there was no
difference in the percentage of infants with a
consolidation in their chest radiograph (RSV-A 27%,
RSV-B 19%, non-typed 22%, P¼ non-significant).
Severity index was significantly higher in patients
where RSV-A was identified (RSV-A: 9.370.4, RSV-
B: 8.470.3, non-subtyped: 8.270.3, P¼ 0.031,
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Table 1 Demographic and clinical characteristics of patients infected with RSV-subtype A, RSV-subtype B or non-
typed cases. ns¼non-significant.
Variable RSV-A n¼ 23 RSV-B n¼ 25 Non-typed n¼ 33 P
Age 3.7 7 0.6 3.2 7 0.5 3.5 7 0.5 ns
Sex (male) 13/23, 57% 11/25, 44% 21/33, 64% ns
Birth weight 3104 7 104 3200 7 90 3087 7 95 ns
Day of disease at admission 3.8 7 0.4 3.2 7 0.4 3.1 7 0.3 ns
Duration of hospitalization (days) 5.4 7 0.6 6.2 7 1.3 5.1 7 0.5 ns
No exposure to tobacco smoke 5/19, 26% 10/24, 42% 10/33, 30% ns
Family history of atopy 7/22, 32% 10/24, 42% 5/32, 16% ns
Fever (X381C) 11/22, 50% 9/25, 36% 15/33, 46% ns
Severity indexn 9.3 7 0.4 8.4 7 0.3 8.2 7 0.3 0.031
nBased on cardiac rate, respiratory rate, presence of wheezing, skin colour and O2 saturation.
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RSV-A vs. RSV-B, P¼ 0.049). All clinical parameters
were more affected in infants with RSV-A infection,
however these differences were not statistically
significant (Table 2).
All infants received oxygen supplementation
until 1 day before discharge. Antibiotics were given
to 6/23 (26%) of the RSV-A group and 6/25 (24%) of
the RSV-B; systemic steroids to 7/23 (30%) of the
RSV-A group and 4/25 (16%) of the RSV-B (not
statistically significant). One infant from each RSV
subtype was admitted to the intensive care unit.
Boys had more severe disease than girls
(8.9670.22 vs. 8.0070.27, P¼ 0.007). Infants o3
months (n¼ 42) had more severe disease than older
ones (8.8670.24 vs. 8.1870.26, P¼ 0.058). Pre-
maturity, low birth weight, family history of atopy,
fever X381C, exposure to tobacco smoke currently
or during pregnancy, and number of siblings were
not different between the groups.
Discussion
In this study, using a composite index that takes
into account several clinical parameters,13 it was
shown that the severity score of infants infected
with RSV-A was higher than the one of infants
infected with RSV-B, or non-subtyped RSV. The
difference was small but statistically significant.
Length of hospitalization was not significantly
different between the groups, possibly because
this parameter is based upon clinical decisions that
cannot be controlled. Young age and male sex
affected disease severity, consistently with other
studies.12
An unexpected weakness of this study was the
considerable number of samples that could not be
subtyped by PCR. Lower viral load and/or the
presence of PCR inhibitors in the samples may
account for this finding. The method used may be
slightly less sensitive for RSV-B,14 however, even in
this case, the reported increased severity of RSV-A
would be strengthened. In a recent study, Hornsleth
and colleagues used PCR for subtyping RSV; how-
ever, they performed the PCR reaction on viral
isolates derived from culture where a very high
viral concentration is present, in contrast to nasal
aspirate samples.9
The discrepancies in the results of different
studies looking into RSV subtype and bronchiolitis
severity need to be further elucidated.4,5,7,8,9,11
Most of the studies have found RSV-A as the most
severe pathogen;5–8 however in some cases, this
effect was lost when confounders were taken into
account in logistic regression models.10 This could
mean that the correlation either does not exist, or
that the power of the study was not enough to
confirm it. In this respect, a meta-analysis of the
various studies could be useful; however, inclusion
criteria, disease definitions, outcome measures and
virus identification methodologies differ widely,
thus making such an approach difficult.
In conclusion, RSV subtype A infection resulted in
more severe bronchiolitis in this cohort of hospita-
lized infants, as in the majority of published
studies. Difference in severity was small and should
be interpreted with caution. However, it is possible
that no single study may be able to account for all
variation between years, locations, immune status
of the community and virulence. This indicates the
need for studies with well-defined inclusion criteria
and outcome measures in order to allow for
successful meta-analyses.
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